Column Group Opportunity III, LP's Net Worth
$17.2 Million
Who is Column Group Opportunity III, LP?
Column Group Opportunity III, LP has an estimated net worth of $17.2 Million. This is based on reported shares across multiple companies, which include NGM BIOPHARMACEUTICALS INC, and Tenaya Therapeutics, Inc..
SEC CIK
Column Group Opportunity III, LP's CIK is 0001931825
Past Insider Trading and Trends
2023 was Column Group Opportunity III, LP's most active year for acquiring shares with 15 total transactions. Column Group Opportunity III, LP's most active month to acquire stocks was the month of December. 2022 saw Column Group Opportunity III, LP paying a total of $26,856,571.71 for 9,995,856 shares, this is the most they've acquired in one year.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
NGM BIOPHARMACEUTICALS INC (NGM) Snapshot price: $1.42
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -21.74M |
—
|
—
| 1K |
Apr 5
| |||
Form 4
| +2.44% | 22.63K |
$0.69 | $15,506.86 | 949.86K |
Nov 15 - Nov 16
| |||
Form 4
| +24.80% | 184.27K |
$5.00 | $921,109.56 | 927.23K |
Jan 30 - Jan 31
| |||
Form 4
| +1.35% | 9.9K |
$5.00 | $49,494.06 | 742.96K |
Jan 23
| |||
Form 4
| +5.49% | 38.14K |
$5.00 | $190,602.67 | 733.06K |
Jan 19 - Jan 20
| |||
Form 4
| +0.78% | 5.38K |
$4.95 | $26,602.81 | 694.92K |
Jan 12
| |||
Form 4
| +81.23% | 309.07K |
$4.79 | $1,479,358.93 | 689.54K |
Jan 10 - Jan 11
| |||
Form 4
| +0.08% | 300 |
$4.98 | $1,493.01 | 380.47K |
Dec 12
| |||
Form 4
| +11.87% | 40.33K |
$5.00 | $201,587.91 | 380.17K |
Nov 21 - Nov 22
| |||
Form 4
| +69.33% | 139.15K |
$4.92 | $684,426.74 | 339.85K |
Nov 3 - Nov 4
| |||
Form 4
| +62.09% | 76.88K |
$4.86 | $373,637.60 | 200.7K |
Oct 27
| |||
Form 4
|
∞
| 123.82K |
$4.81 | $595,428.06 | 123.82K |
Oct 25 - Oct 26
| |||
| No matching records found | |||||||||
Tenaya Therapeutics, Inc. (TNYA) Snapshot price: $4.39
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +19.53% | 2.22M |
$4.50 | $9,999,999.00 | 13.6M |
Feb 12
| |||
Form 4
| +0.06% | 6.78K |
$2.60 | $17,595.57 | 11.38M |
Mar 10
| |||
Form 4
| +15.20% | 1.5M |
$2.60 | $3,900,000.00 | 11.37M |
Feb 8
| |||
Form 4
| +0.71% | 69.74K |
$2.50 | $174,201.05 | 9.87M |
Jan 19
| |||
Form 4
| +1.93% | 185.15K |
$2.51 | $464,827.06 | 9.8M |
Jan 17 - Jan 18
| |||
Form 4
|
∞
| 9.62M |
$2.60 | $24,999,998.40 | 9.62M |
Nov 21
| |||
| No matching records found | |||||||||